- IN₹312.87m
- IN₹290.58m
- IN₹322.32m
Annual income statement for TCM, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 30th | 2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | Interim Report | ARS | ARS |
| Standards: | IAS | IAS | — | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 9.2 | 42.5 | 35.5 | 73.5 | 322 |
| Cost of Revenue | |||||
| Gross Profit | 2.68 | 23.7 | 9.49 | 15.4 | 89.8 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 17.6 | 51.8 | 103 | 114 | 348 |
| Operating Profit | -8.44 | -9.27 | -67.6 | -40.5 | -25.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 3.05 | 3.07 | -58.8 | -43 | -22.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 3.05 | 1.18 | -58.8 | -42.7 | -22.9 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 3.05 | 1.18 | -51.4 | -40 | -19.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 3.05 | 1.18 | -51.4 | -40 | -19.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.897 | 0.348 | -6.35 | -5.97 | -2.91 |